Clinical Trials Browser

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

Locally Advanced Cervical Adenocarcinoma

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Uterine Cervical Neoplasms, Vaginal Neoplasms

Locally Advanced Cervical Carcinoma

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

Carcinoma, Uterine Cervical Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Advanced Cervical Cancer

Ovarian Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms, Vaccinia

Uterine Cervical Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Locally Advanced Cervical Cancer

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Locally Advanced Cervical Carcinoma

Uterine Cervical Neoplasms

Locally Advanced Cervical Cancer

Endometrial Clear Cell Adenocarcinoma

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Endometrial Neoplasms

Uterine Cervical Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

Ovarian Germ Cell Cancer, Ovarian Neoplasms

Ovarian Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Ovarian Neoplasms

Gestational Trophoblastic Disease

Uterine Cervical Neoplasms

Ovarian Neoplasms

Recurrent Uterine Corpus Carcinoma

Endometrial Clear Cell Adenocarcinoma

Ovarian Germ Cell Cancer, Teratoma, Testicular Neoplasms, Endodermal Sinus Tumor

Endometrial Neoplasms

Uterine Cervical Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Uterine Cervical Neoplasms

Clinical Trials

KEYNOTE-B21

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

TroFuse-036

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

A Clinical Study of QL1706 Combined With Chemotherapy as Neoadjuvant Therapy for High-Risk Locally Advanced Cervical Cancer

KEYNOTE-C93

BEATcc

HOTT

A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer

OVHIPEC-2

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

NELCER

KEYNOTE-A18

FOCUS / KOV-04

KEYNOTE-826

Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy

A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

MICHELE

Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery

A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer

INTERLACE

Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline

AK104-305

AddChemo

CALLA

Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol

A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma

Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer

PORTEC-3

ONCOCOL01

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

MOGCT-01

SCST-01

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer

Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2)

Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor

A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer

Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer

Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors

Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer

FERMATA

Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer

Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer

Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer

Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer

TACO